Skip to main content

HIV infection.

Publication ,  Journal Article
Bekker, L-G; Beyrer, C; Mgodi, N; Lewin, SR; Delany-Moretlwe, S; Taiwo, B; Masters, MC; Lazarus, JV
Published in: Nat Rev Dis Primers
August 17, 2023

The AIDS epidemic has been a global public health issue for more than 40 years and has resulted in ~40 million deaths. AIDS is caused by the retrovirus, HIV-1, which is transmitted via body fluids and secretions. After infection, the virus invades host cells by attaching to CD4 receptors and thereafter one of two major chemokine coreceptors, CCR5 or CXCR4, destroying the host cell, most often a T lymphocyte, as it replicates. If unchecked this can lead to an immune-deficient state and demise over a period of ~2-10 years. The discovery and global roll-out of rapid diagnostics and effective antiretroviral therapy led to a large reduction in mortality and morbidity and to an expanding group of individuals requiring lifelong viral suppressive therapy. Viral suppression eliminates sexual transmission of the virus and greatly improves health outcomes. HIV infection, although still stigmatized, is now a chronic and manageable condition. Ultimate epidemic control will require prevention and treatment to be made available, affordable and accessible for all. Furthermore, the focus should be heavily oriented towards long-term well-being, care for multimorbidity and good quality of life. Intense research efforts continue for therapeutic and/or preventive vaccines, novel immunotherapies and a cure.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Rev Dis Primers

DOI

EISSN

2056-676X

Publication Date

August 17, 2023

Volume

9

Issue

1

Start / End Page

42

Location

England

Related Subject Headings

  • Quality of Life
  • Immunotherapy
  • Humans
  • HIV Infections
  • Epidemics
  • Acquired Immunodeficiency Syndrome
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bekker, L.-G., Beyrer, C., Mgodi, N., Lewin, S. R., Delany-Moretlwe, S., Taiwo, B., … Lazarus, J. V. (2023). HIV infection. Nat Rev Dis Primers, 9(1), 42. https://doi.org/10.1038/s41572-023-00452-3
Bekker, Linda-Gail, Chris Beyrer, Nyaradzo Mgodi, Sharon R. Lewin, Sinead Delany-Moretlwe, Babafemi Taiwo, Mary Clare Masters, and Jeffrey V. Lazarus. “HIV infection.Nat Rev Dis Primers 9, no. 1 (August 17, 2023): 42. https://doi.org/10.1038/s41572-023-00452-3.
Bekker L-G, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, et al. HIV infection. Nat Rev Dis Primers. 2023 Aug 17;9(1):42.
Bekker, Linda-Gail, et al. “HIV infection.Nat Rev Dis Primers, vol. 9, no. 1, Aug. 2023, p. 42. Pubmed, doi:10.1038/s41572-023-00452-3.
Bekker L-G, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. HIV infection. Nat Rev Dis Primers. 2023 Aug 17;9(1):42.

Published In

Nat Rev Dis Primers

DOI

EISSN

2056-676X

Publication Date

August 17, 2023

Volume

9

Issue

1

Start / End Page

42

Location

England

Related Subject Headings

  • Quality of Life
  • Immunotherapy
  • Humans
  • HIV Infections
  • Epidemics
  • Acquired Immunodeficiency Syndrome
  • 3202 Clinical sciences
  • 1103 Clinical Sciences